The proposed rule amendment is intended to extend the fee reductions for some application and initial licensure fees until February 1, 2021.

 

DEPARTMENT OF HEALTH

Board of Medicine

RULE NO.:RULE TITLE:

64B8-3.002Application, Certification, Registration, and Licensure Fees

PURPOSE AND EFFECT: The proposed rule amendment is intended to extend the fee reductions for some application and initial licensure fees until February 1, 2021.

SUMMARY: The proposed rule amendment extends the fee reductions for some application and initial licensure fees until February 1, 2021.

SUMMARY OF STATEMENT OF ESTIMATED REGULATORY COSTS AND LEGISLATIVE RATIFICATION:

The Agency has determined that this will not have an adverse impact on small business or likely increase directly or indirectly regulatory costs in excess of $200,000 in the aggregate within one year after the implementation of the rule. A SERC has not been prepared by the Agency.

The Agency has determined that the proposed rule is not expected to require legislative ratification based on the statement of estimated regulatory costs or if no SERC is required, the information expressly relied upon and described herein: During discussion of the economic impact of this rule at its Board meeting, the Board concluded that this rule change will not have any impact on licensees and their businesses or the businesses that employ them. The rule will not increase any fees, business costs, personnel costs, will not decrease profit opportunities, and will not require any specialized knowledge to comply. This change will not increase any direct or indirect regulatory costs. Hence, the Board determined that a Statement of Estimated Regulatory Costs (SERC) was not necessary and that the rule will not require ratification by the Legislature. No person or interested party submitted additional information regarding the economic impact at that time.

Any person who wishes to provide information regarding a statement of estimated regulatory costs, or provide a proposal for a lower cost regulatory alternative must do so in writing within 21 days of this notice.

RULEMAKING AUTHORITY: 456.013, 456.025, 458.309, 458.311, 458.3115, 458.3124, 458.313, 458.3135, 458.3137, 458.3145, 458.315, 458.3151, 458.316, 458.3165, 458.317, 458.345 FS.

LAW IMPLEMENTED: 456.013, 456.025, 458.311, 458.3115, 458.3124, 458.313, 458.3135, 458.3137, 458.3145, 458.315, 458.3151, 458.316, 458.3165, 458.317, 458.345 FS.

IF REQUESTED WITHIN 21 DAYS OF THE DATE OF THIS NOTICE, A HEARING WILL BE SCHEDULED AND ANNOUNCED IN THE FAR.

THE PERSON TO BE CONTACTED REGARDING THE PROPOSED RULE IS: Claudia Kemp, J.D., Executive Director, Board of Medicine/MQA, 4052 Bald Cypress Way, Bin # C03, Tallahassee, Florida 32399-3253.

 

THE FULL TEXT OF THE PROPOSED RULE IS:

 

64B8-3.002 Application, Certification, Registration, and Licensure Fees. The following fees are prescribed by the Board:

(1) through (9) No change.

(10) The following fee reductions shall remain in effect until February 1, 2021 A one-time reduction in fees until February 1, 2019, shall be as follows:

(a) An application fee in the amount of $350.00 for a person desiring to obtain the following:

1. A license by examination, as provided in Section 458.311, F.S.

2. A license by endorsement, as provided in Section 458.313, F.S.

3. A medical faculty certificate, as provided in Section 458.3145, F.S.

(b) An initial certification fee in the amount of $350.00 for a person who is issued a temporary certificate to practice in areas of critical need, temporary certificate for active duty military and veterans practicing in areas of critical need, public health certificate, public psychiatry certificate, or medical facility certificate and the initial license fee for a person who is issued a license to practice as a physician as provided in Sections 458.311 and 458.313, F.S., or a limited license as provided in Section 458.317, F.S.

Rulemaking Authority 456.013, 456.025, 458.309, 458.311, 458.3115, 458.3124, 458.313, 458.3135, 458.3137, 458.3145, 458.315, 458.3151, 458.316, 458.3165, 458.317, 458.345 FS. Law Implemented 456.013, 456.025, 458.311, 458.3115, 458.3124, 458.313, 458.3135, 458.3137, 458.3145, 458.315, 458.3151, 458.316, 458.3165, 458.317, 458.345 FS. History–New 12-5-79, Amended 11-10-82, 8-11-85, 10-24-85, Formerly 21M-19.02, Amended 12-4-86, 11-3-87, 7-4-88, 10-23-89, 11-12-89, 11-11-90, 1-16-91, 1-9-92, 2-10-92, 9-7-92, Formerly 21M-19.002, Amended 9-21-93, Formerly 61F6-19.002, Amended 2-13-95, 2-20-96, 6-24-96, Formerly 59R-3.002, Amended 6-7-98, 8-11-98, 11-22-98, 12-14-99, 1-31-01, 11-20-01, 10-19-03, 12-2-03, 1-26-04, 4-12-04, 12-17-12, 3-18-13, 1-9-14, 9-10-14, 11-6-17,              .

 

NAME OF PERSON ORIGINATING PROPOSED RULE: Rules/Legislative Committee, Board of Medicine

NAME OF AGENCY HEAD WHO APPROVED THE PROPOSED RULE: Board of Medicine

DATE PROPOSED RULE APPROVED BY AGENCY HEAD: December 7, 2018

DATE NOTICE OF PROPOSED RULE DEVELOPMENT PUBLISHED IN FAR: December 28, 2018